Carlos Beas-Zarate

Dr. Carlos Beas-Zarate


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2018 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
JJJosé Jarero-Basulto
José Jarero-Basulto
YGYadira Gasca-Martínez
Yadira Gasca-Martínez
MCMartha Catalina Rivera Cervantes
Martha Catalina Rivera Cervantes
MUMónica E. Ureña-Guerrero
Mónica E. Ureña-Guerrero
AFAlfredo I. Feria-Velasco
Alfredo I. Feria-Velasco
CBCarlos Beas-Zarate
Carlos Beas-Zarate
Undoubtedly, one of the most interesting topics in the field of neuroscience is the ability of the central nervous system to respond to different stimuli (normal or pathological) by modifying its structure and function, either transiently or permanently, by generating neural cells and new connections in a process known as neuroplasticity. According to the large amount of evidence reported in the literature, many stimuli, such as environmental pressures, changes in the internal dynamic steady state of the organism and even injuries or illnesses (e.g., epilepsy) may induce neuroplasticity. Epilepsy and neuroplasticity seem to be closely related, as the two processes could positively affect one another. Thus, in this review, we analysed some neuroplastic changes triggered in the hippocampus in response to seizure-induced neuronal damage and how these changes could lead to the establishment of temporal lobe epilepsy, the most common type of focal human epilepsy.

26 November 2020 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
JJJosé Jarero-Basulto
José Jarero-Basulto
MCMartha Catalina Rivera Cervantes
Martha Catalina Rivera Cervantes
DGDeisy Gasca-Martínez
Deisy Gasca-Martínez
FGFrancisco García-Sierra
Francisco García-Sierra
YGYadira Gasca-Martínez
Yadira Gasca-Martínez
CBCarlos Beas-Zarate
Carlos Beas-Zarate
Substantial evidence in the literature demonstrates the pleiotropic effects of the administration of recombinant human erythropoietin (rhEPO) and its molecular variants in different tissues and organs, including the brain. Some of these reports suggest that the chemical properties of this molecule by itself or in combination with other agents (e.g., growth factors) could provide the necessary pharmacological characteristics to be considered a potential protective agent in neurological disorders such as Alzheimer’s disease (AD). AD is a degenerative disorder of the brain, characterized by an aberrant accumulation of amyloid β (Aβ) and hyperphosphorylated tau (tau-p) proteins in the extracellular and intracellular space, respectively, leading to inflammation, oxidative stress, excitotoxicity, and other neuronal alterations that compromise cell viability, causing neurodegeneration in the hippocampus and the cerebral cortex. Unfortunately, to date, it lacks an effective therapeutic strategy for its treatment. Therefore, in this review, we analyze the evidence regarding the effects of exogenous EPOs (rhEPO and its molecular variants) in several in vivo and in vitro Aβ and tau-p models of AD-type neurodegeneration, to be considered as an alternative protective treatment to this condition. Particularly, we focus on analyzing the differential effect of molecular variants of rhEPO when changes in doses, route of administration, duration of treatment or application times, are evaluated for the improved cellular alterations generated in this disease. This narrative review shows the evidence of the effectiveness of the exogenous EPOs as potential therapeutic molecules, focused on the mechanisms that establish cellular damage and clinical manifestation in the AD.

13 August 2020 in Cells
Verified
Journal Article
Open access
PDF file
RCRubén Darío Castro-Torres
Rubén Darío Castro-Torres
OFOriol Busquets Figueras
Oriol Busquets Figueras
APAntoni Parcerisas
Antoni Parcerisas
EVEster Verdaguer
Ester Verdaguer
JOJordi Olloquequi
Jordi Olloquequi
CACarme Auladell
Carme Auladell
The c-Jun N-terminal Kinases (JNKs) are a group of regulatory elements responsible for the control of a wide array of functions within the cell. In the central nervous system (CNS), JNKs are involved in neuronal polarization, starting from the cell division of neural stem cells and ending with their final positioning when migrating and maturing. This review will focus mostly on isoform JNK1, the foremost contributor of total JNK activity in the CNS. Throughout the text, research from multiple groups will be summarized and discussed in order to describe the involvement of the JNKs in the different steps of neuronal polarization. The data presented support the idea that isoform JNK1 is highly relevant to the regulation of many of the processes that occur in neuronal development in the CNS.

6 March 2020 in Journal of Molecular Neuroscience
Verified
Journal Article
Closed access
PDF file
RCRubén Darío Castro-Torres
Rubén Darío Castro-Torres
MUMónica E. Ureña-Guerrero
Mónica E. Ureña-Guerrero
LCLilia Morales Chacon
Lilia Morales Chacon
LLLourdes Lorigados
Lourdes Lorigados
BDBárbara O. Estupiñan Díaz
Bárbara O. Estupiñan Díaz
CBCarlos Beas-Zarate
Carlos Beas-Zarate

19 February 2019 in Frontiers in Neuroscience
Verified
Journal Article
Open access
PDF file
MCMartha Catalina Rivera Cervantes
Martha Catalina Rivera Cervantes
JJJosé Jarero-Basulto
José Jarero-Basulto
JMJusto Murguía-Castillo
Justo Murguía-Castillo
AMAlejandra Guadalupe Marín-López
Alejandra Guadalupe Marín-López
YGYadira Gasca-Martínez
Yadira Gasca-Martínez
CBCarlos Beas-Zarate
Carlos Beas-Zarate
In vitro and in vivo experimental evidence has contributed important knowledge regarding the antiapoptotic effect mediated by EPO signaling in the damaged brain, particularly through different models with a hypoxic component. However, little emphasis has been placed on the effectiveness of rhEPO administration against cellular alterations caused by in vivo excitotoxicity or on the molecular mechanism that regulates this effect. In this study, we investigated the effects of a single dose of rhEPO on hippocampal damage induced by subcutaneous application of monosodium glutamate (MSG) on postnatal days 1, 3, 5 and 7 in neonatal rats. We found that a dose of 1000 IU/kg of b.w. administered 24 h after MSG had the greatest protective effect. In addition, we analyzed changes in gene expression, particularly in 3 key molecules involved in EPO-mediated signaling (EPO, EPOR and βcR). We observed that the expression of EPO and EPOR was differentially modified at both the mRNA and protein levels under the evaluated conditions, while the expression of the βcR gene was substantially increased. Our data suggest that a low dose of rhEPO is sufficient to induce cellular protection under these experimental conditions and that the molecular changes could be a positive feedback mechanism, mediated by reactive astrocytes in association with in vivo neuroprotective mechanisms.

Verified
Journal Article
Open access
PDF file
RCRubén Darío Castro-Torres
Rubén Darío Castro-Torres
JOJordi Olloquequi
Jordi Olloquequi
MEMiren Ettcheto
Miren Ettcheto
PCPablo Caruana
Pablo Caruana
LSLuke Steele
Luke Steele
CACarme Auladell
Carme Auladell
(1) Background: The c-Jun-NH2-terminal protein kinase (JNK) is a mitogen-activated protein kinase involved in regulating physiological processes in the central nervous system. However, the dual genetic deletion of Mkk4 and Mkk7 (upstream activators of JNK) in adult mice is not reported. The aim of this study was to induce the genetic deletion of Mkk4/Mkk7 in adult mice and analyze their effect in hippocampal neurogenesis. (2) Methods: To achieve this goal, Actin-CreERT2 (Cre+/−), Mkk4flox/flox, Mkk7flox/flox mice were created. The administration of tamoxifen in these 2-month-old mice induced the gene deletion (Actin-CreERT2 (Cre+/−), Mkk4∆/∆, Mkk7∆/∆ genotype), which was verified by PCR, Western blot, and immunohistochemistry techniques. (3) Results: The levels of MKK4/MKK7 at 7 and 14 days after tamoxifen administration were not eliminated totally in CNS, unlike what happens in the liver and heart. These data could be correlated with the high levels of these proteins in CNS. In the hippocampus, the deletion of Mkk4/Mkk7 induced a misalignment position of immature hippocampal neurons together with alterations in their dendritic architecture pattern and maturation process jointly to the diminution of JNK phosphorylation. (4) Conclusion: All these data supported that the MKK4/MKK7–JNK pathway has a role in adult neurogenic activity.